vs
Insulet Corporation（PODD）与RXO, Inc.（RXO）财务数据对比。点击上方公司名可切换其他公司
RXO, Inc.的季度营收约是Insulet Corporation的1.9倍（$1.5B vs $783.7M），Insulet Corporation净利率更高（13.0% vs -3.1%，领先16.1%），Insulet Corporation同比增速更快（31.2% vs -11.9%），Insulet Corporation自由现金流更多（$48.2M vs $-9.0M），过去两年Insulet Corporation的营收复合增速更高（33.2% vs 26.8%）
Insulet Corporation是深耕糖尿病治疗领域的医疗器械企业，核心产品为胰岛素泵，通过持续皮下输注胰岛素的疗法为患者给药。其产品通常由泵主体、一次性胰岛素储药仓，以及包含皮下植入套管和连接管路的一次性输注套件构成，满足不同患者的治疗需求。
RXO是总部位于美国的头部运输及物流解决方案供应商，核心业务覆盖货运经纪、大件商品最后一公里配送、运输管理服务与全链路供应链优化支持，主要服务北美制造业、零售业及电商领域的客户。
PODD vs RXO — 直观对比
营收规模更大
RXO
是对方的1.9倍
$783.7M
营收增速更快
PODD
高出43.0%
-11.9%
净利率更高
PODD
高出16.1%
-3.1%
自由现金流更多
PODD
多$57.2M
$-9.0M
两年增速更快
PODD
近两年复合增速
26.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $783.7M | $1.5B |
| 净利润 | $101.6M | $-46.0M |
| 毛利率 | 72.6% | — |
| 营业利润率 | 18.7% | -2.9% |
| 净利率 | 13.0% | -3.1% |
| 营收同比 | 31.2% | -11.9% |
| 净利润同比 | 0.9% | -84.0% |
| 每股收益（稀释后） | $1.42 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PODDRXO
| Q4 25 | $783.7M | $1.5B | ||
| Q3 25 | $706.3M | $1.4B | ||
| Q2 25 | $649.1M | $1.4B | ||
| Q1 25 | $569.0M | $1.4B | ||
| Q4 24 | $597.5M | $1.7B | ||
| Q3 24 | $543.9M | $1.0B | ||
| Q2 24 | $488.5M | $930.0M | ||
| Q1 24 | $441.7M | $913.0M |
净利润PODDRXO
| Q4 25 | $101.6M | $-46.0M | ||
| Q3 25 | $87.6M | $-14.0M | ||
| Q2 25 | $22.5M | $-9.0M | ||
| Q1 25 | $35.4M | $-31.0M | ||
| Q4 24 | $100.7M | $-25.0M | ||
| Q3 24 | $77.5M | $-243.0M | ||
| Q2 24 | $188.6M | $-7.0M | ||
| Q1 24 | $51.5M | $-15.0M |
毛利率PODDRXO
| Q4 25 | 72.6% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 69.7% | — | ||
| Q1 25 | 71.9% | — | ||
| Q4 24 | 72.1% | — | ||
| Q3 24 | 69.3% | — | ||
| Q2 24 | 67.7% | — | ||
| Q1 24 | 69.5% | — |
营业利润率PODDRXO
| Q4 25 | 18.7% | -2.9% | ||
| Q3 25 | 16.7% | -0.5% | ||
| Q2 25 | 18.7% | — | ||
| Q1 25 | 15.6% | -2.1% | ||
| Q4 24 | 18.3% | -1.4% | ||
| Q3 24 | 16.2% | -1.9% | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | 12.9% | -1.3% |
净利率PODDRXO
| Q4 25 | 13.0% | -3.1% | ||
| Q3 25 | 12.4% | -1.0% | ||
| Q2 25 | 3.5% | -0.6% | ||
| Q1 25 | 6.2% | -2.2% | ||
| Q4 24 | 16.9% | -1.5% | ||
| Q3 24 | 14.2% | -23.4% | ||
| Q2 24 | 38.6% | -0.8% | ||
| Q1 24 | 11.7% | -1.6% |
每股收益（稀释后）PODDRXO
| Q4 25 | $1.42 | $-0.28 | ||
| Q3 25 | $1.24 | $-0.08 | ||
| Q2 25 | $0.32 | $-0.05 | ||
| Q1 25 | $0.50 | $-0.18 | ||
| Q4 24 | $1.38 | $-0.17 | ||
| Q3 24 | $1.08 | $-1.81 | ||
| Q2 24 | $2.59 | $-0.06 | ||
| Q1 24 | $0.73 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $17.0M |
| 总债务越低越好 | $930.8M | $387.0M |
| 股东权益账面价值 | $1.5B | $1.5B |
| 总资产 | $3.2B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.61× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资PODDRXO
| Q4 25 | — | $17.0M | ||
| Q3 25 | — | $25.0M | ||
| Q2 25 | — | $18.0M | ||
| Q1 25 | — | $16.0M | ||
| Q4 24 | — | $35.0M | ||
| Q3 24 | — | $55.0M | ||
| Q2 24 | — | $7.0M | ||
| Q1 24 | — | $7.0M |
总债务PODDRXO
| Q4 25 | $930.8M | $387.0M | ||
| Q3 25 | $934.9M | $387.0M | ||
| Q2 25 | $939.0M | $387.0M | ||
| Q1 25 | $1.6B | $387.0M | ||
| Q4 24 | $1.3B | $351.0M | ||
| Q3 24 | $1.4B | $352.0M | ||
| Q2 24 | $1.4B | $370.0M | ||
| Q1 24 | $1.4B | $351.0M |
股东权益PODDRXO
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.4B | $1.6B | ||
| Q2 25 | $1.5B | $1.6B | ||
| Q1 25 | $1.3B | $1.6B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $1.1B | $1.7B | ||
| Q2 24 | $998.4M | $579.0M | ||
| Q1 24 | $790.7M | $582.0M |
总资产PODDRXO
| Q4 25 | $3.2B | $3.3B | ||
| Q3 25 | $3.0B | $3.2B | ||
| Q2 25 | $3.5B | $3.2B | ||
| Q1 25 | $3.5B | $3.3B | ||
| Q4 24 | $3.1B | $3.4B | ||
| Q3 24 | $3.0B | $3.4B | ||
| Q2 24 | $2.9B | $1.8B | ||
| Q1 24 | $2.6B | $1.8B |
负债/权益比PODDRXO
| Q4 25 | 0.61× | 0.25× | ||
| Q3 25 | 0.68× | 0.24× | ||
| Q2 25 | 0.64× | 0.24× | ||
| Q1 25 | 1.21× | 0.24× | ||
| Q4 24 | 1.07× | 0.22× | ||
| Q3 24 | 1.21× | 0.21× | ||
| Q2 24 | 1.36× | 0.64× | ||
| Q1 24 | 1.72× | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.3M | $7.0M |
| 自由现金流经营现金流 - 资本支出 | $48.2M | $-9.0M |
| 自由现金流率自由现金流/营收 | 6.2% | -0.6% |
| 资本支出强度资本支出/营收 | 17.2% | 1.1% |
| 现金转化率经营现金流/净利润 | 1.80× | — |
| 过去12个月自由现金流最近4个季度 | $377.7M | $-8.0M |
8季度趋势，按日历期对齐
经营现金流PODDRXO
| Q4 25 | $183.3M | $7.0M | ||
| Q3 25 | $125.7M | $23.0M | ||
| Q2 25 | $196.5M | $23.0M | ||
| Q1 25 | $63.8M | $-2.0M | ||
| Q4 24 | $147.7M | $-7.0M | ||
| Q3 24 | $98.5M | $-7.0M | ||
| Q2 24 | $96.5M | $-5.0M | ||
| Q1 24 | $87.6M | $7.0M |
自由现金流PODDRXO
| Q4 25 | $48.2M | $-9.0M | ||
| Q3 25 | $100.1M | $9.0M | ||
| Q2 25 | $177.9M | $9.0M | ||
| Q1 25 | $51.5M | $-17.0M | ||
| Q4 24 | $94.1M | $-19.0M | ||
| Q3 24 | $71.8M | $-18.0M | ||
| Q2 24 | $74.0M | $-16.0M | ||
| Q1 24 | $65.5M | $-4.0M |
自由现金流率PODDRXO
| Q4 25 | 6.2% | -0.6% | ||
| Q3 25 | 14.2% | 0.6% | ||
| Q2 25 | 27.4% | 0.6% | ||
| Q1 25 | 9.1% | -1.2% | ||
| Q4 24 | 15.7% | -1.1% | ||
| Q3 24 | 13.2% | -1.7% | ||
| Q2 24 | 15.1% | -1.7% | ||
| Q1 24 | 14.8% | -0.4% |
资本支出强度PODDRXO
| Q4 25 | 17.2% | 1.1% | ||
| Q3 25 | 3.6% | 1.0% | ||
| Q2 25 | 2.9% | 1.0% | ||
| Q1 25 | 2.2% | 1.0% | ||
| Q4 24 | 9.0% | 0.7% | ||
| Q3 24 | 4.9% | 1.1% | ||
| Q2 24 | 4.6% | 1.2% | ||
| Q1 24 | 5.0% | 1.2% |
现金转化率PODDRXO
| Q4 25 | 1.80× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 8.73× | — | ||
| Q1 25 | 1.80× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 0.51× | — | ||
| Q1 24 | 1.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
